arrow
Back
H

Harpreet Wasan

imperial college london

66H-index
430Paper Count
3.0WCitation Count
Published Papers 138
Publication Date
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3
err2026-05-31
err0
errOAAI
errS. Kopetz; J. Tabernero; S. Lonardi; L. Shen; H.S. Wasan; T. Yoshino; E. Van Cutsem; T.W. Kim; C. Eng; F. Ciardiello; J. Desai; T.S. Maughan; R. Yaeger; T. Usari; Xiaoxi Zhang; E. Beyzarov; A. Mori; E. Whalley; Xiaosong Zhang; E. Elez
errShare
errSave
Advanced Ampullary Cancer: post-hoc analysis of the ABC-01, -02 and -03 clinical trials
err2025-12-14
err0
errOAAI
errAngela Lamarca; Paul Ross; Harpreet S Wasan; Richard A Hubner; Mairéad G McNamara; Andre Lopes; Daniel Palmer; Juan W Valle; John Bridgewater
errShare
errSave
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine
err2025-07-29
err0
PREAI
errEleni Vrana; Hayley Timmins; Ashley Osborne; Rebecca Cox; Harpreet Wasan; Yuk Ting Ma; Arvind Arora; Olusola Faluyi; Roopinder Gillmore; Pippa Corrie; Paul Miller; Seema Arif; Joanna Canham; Charlotte Martin; Muhammad Riaz; Tongtong Shi; Melissa Frizziero; Victoria Foy; Richard A Hubner; Helen Morement; John Bridgewater; Richard Adams; Juan W Valle; Mairéad G McNamara
errShare
errSave
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study
err2025-05-09
err0
errOAAI
errKopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
errShare
errSave
A targeted literature review on the impact of tailored interventions on patient outcomes in oncology
err2025-04-30
err0
errOAAI
errFerrier, Graham; Filipovic, Aleksandra; Wasan, Harpreet; di Pietro, Alessandra; Mittal, Deepali; Kamath, Geetanjali; Kharawala, Saifuddin; Mehmud, Faisal
errShare
errSave
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
err2024-09-23
err1
errOAAI
errKopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
errShare
errSave
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
err2024-09-01
err0
PREAI
errMukherjee, Somnath; Qi, Cathy; Shaw, Rachel; Jones, Christopher M.; Bridgewater, John A.; Radhakrishna, Ganesh; Patel, Neel; Holmes, Jane; Virdee, Pradeep S.; Tranter, Bethan; Parsons, Philip; Falk, Stephen; Wasan, Harpreet S.; Ajithkumar, Thankamma, V; Holyoake, Daniel; Roy, Rajarshi; Scott-Brown, Martin; Hurt, Christopher N.; O'Neill, Eric; Sebag-Montefiore, David; Maughan, Tim S.; Hawkins, Maria A.; Corrie, Pippa
errShare
errSave
Encorafenib plus cetuximab (EC) plus FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)
err2024-09-01
err1
PREAI
errTabernero, J.; Yoshino, T.; Kim, T. W.; Yaeger, R.; Desai, J.; Wasan, H. S.; Van Cutsem, E.; Ciardiello, F.; Maughan, T.; Eng, C.; Tie, J.; Elez Fernandez, M. E.; Lonardi, S.; Usari, T.; Hahn, E.; Dychter, S.; Ferrier, G.; Zhang, X.; Kopetz, S.
errShare
errSave
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
err2024-08-08
err1
errOAAI
errHarding, James J.; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A.; Chen, Emerson Y.; Kim, Dong Uk; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Lindsey, Stacie; Bachini, Melinda; Morement, Helen; Boyken, Lisa; Ma, Jiafang; Garfin, Phillip; Pant, Shubham
errShare
errSave
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial
err2024-08-01
err1
PREAI
errGogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik
errShare
errSave
Screening and COnsensus based on Practices and Evidence (SCOPE): Real-world survey on Japanese and rest-of-world practice patterns in resectable pancreatic cancer
err2023-11-01
err0
PREAI
errFujii, T.; Prager, G.; Boeck, S.; Santini, D.; Modest, D. P.; Rivera, F.; Phelip, J. M.; Dioca, M. H.; Smyth, E.; Zaanan, A.; Wasan, H. S.; Furuse, J.
errShare
errSave
Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study
err2023-10-01
err0
errOAAI
errWasan, H. S.; Harding, J. J.; Fan, J.; Oh, D-Y.; Choi, H. J.; Kim, J. W.; Chang, H-M.; Bao, L.; Sun, H.; Macarulla, T.; Xie, F.; Metges, J-P.; Ying, J.; Bridgewater, J. A.; Tejani, M.; Chen, E. Y.; Ducreux, M. P.; Ma, J.; Garfin, P.; Pant, S.
errShare
errSave
CUP-ONE trial: A prospective double-blind validation of molecular classifiers in the diagnosis of cancer of unknown primary and clinical outcomes
err2023-10-01
err2
PREAI
errWasan, H. S.; Wang, J.; McCartney, E. M. Elaine; Soifer, H.; Treuner, K.; Zhang, Y.; Schnabel, C.; Carty, K.; McMahon, L.; Evans, T. R. J.; Nicolson, M. C.; Thygesen, H.; Roche, J. R.; Oien, K. A.
errShare
errSave
Advanced extrahepatic cholangiocarcinoma: Post-hoc analysis of the ABC-01,-02 and-03 clinical trials
err2023-10-01
err0
PREAI
errLamarca, A.; Ross, P. J.; Wasan, H. S.; Hubner, R.; McNamara, M. G.; Lopes, A.; Palmer, D.; Valle, J. W.; Bridgewater, J. A.
errShare
errSave
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
err2023-09-01
err6
errOAAI
errRaimondi, Alessandra; Nichetti, Federico; Stahler, Arndt; Wasan, Harpreet S.; Aranda, Enrique; Randon, Giovanni; Kurreck, Annika; Meade, Angela M.; Diaz-Rubio, Eduardo; Niger, Monica; Stintzing, Sebastian; Palermo, Federica; Trarbach, Tanja; Prisciandaro, Michele; Sommerhauser, Greta; Fisher, David; Morano, Federica; Pietrantonio, Filippo; Modest, Dominik P.
errShare
errSave
Clinical characteristics, efficacy, and safety in patients receiving second- or third-line encorafenib plus cetuximab (E plus C) vs control for metastatic colorectal cancer (mCRC): BEACON CRC post hoc analysis
err2023-06-01
err3
errOAAI
errTabernero, J.; Van Cutsem, E.; Yoshino, T.; Yaeger, R.; Wasan, H.; Desai, J.; Ciardiello, F.; Alkuzweny, B.; Zhang, X.; Guenzil, C.; Kopetz, S.
errShare
errSave
Real-world screening and consensus based on practices and evidence (SCOPE) in gastrointestinal cancers: Practice patterns in metastatic pancreatic cancer
err2023-06-01
err0
errOAAI
errPrager, G.; Fujii, T.; Santini, D.; Modest, D.; Rivera, F.; Phelip, J.; Dioca, M.; Smyth, E.; Zaanan, A.; Wasan, H.; Boeck, S.
errShare
errSave
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
err2023-06-01
err62
errOAAI
errDucreux, M.; Abou-Alfa, G. K.; Bekaii-Saab, T.; Berlin, J.; Cervantes, A.; de Baere, T.; Eng, C.; Galle, P.; Gill, S.; Gruenberger, T.; Haustermans, K.; Lamarca, A.; Laurent-Puig, P.; Llovet, J. M.; Lordick, F.; Macarulla, T.; Mukherji, D.; Muro, K.; Obermannova, R.; O'Connor, J. -M.; O'Reilly, E. M.; Osterlund, P.; Philip, P.; Prager, G.; Ruiz-Garcia, E.; Sangro, B.; Seufferlein, T.; Tabernero, J.; Verslype, C.; Wasan, H.; Van Cutsem, E.
errShare
errSave
The screening and consensus based on practices and evidence (SCOPE) survey - results of a real-world survey on practice patterns in gastric cancer
err2023-06-01
err0
errOAAI
errSmyth, E.; Modest, D.; Prager, G.; Santini, D.; Rivera, F.; Phelip, J.; Dioca, M.; Wasan, H.; Boeck, S.; Zaanan, A.
errShare
errSave
Current practices in metastatic colorectal cancer: Results from the real-world screening and consensus based on practices and evidence (SCOPE) program in gastrointestinal cancers
err2023-06-01
err0
errOAAI
errPrager, G.; Santini, D.; Modest, D.; Rivera, F.; Phelip, J.; Dioca, M.; Smyth, E.; Zaanan, A.; Boeck, S.; Wasan, H.
errShare
errSave